Primary-source health, pharma, and med-sci headlines (FDA, NIH, WHO, CMS, Nature Medicine, npj Digital Medicine, medRxiv), aggregated daily at drjeremytabernero.org/news. Every item links to its original source.https://drjeremytabernero.org/en-ushttps://www.nature.com/articles/s41746-026-03133-zhttps://www.nature.com/articles/s41746-026-03133-zSat, 08 Aug 2026 00:00:00 GMTJournalshttps://www.nature.com/articles/s41746-026-03113-3https://www.nature.com/articles/s41746-026-03113-3Sat, 08 Aug 2026 00:00:00 GMTJournalshttps://www.nature.com/articles/s41746-026-03043-0https://www.nature.com/articles/s41746-026-03043-0Sat, 08 Aug 2026 00:00:00 GMTJournalshttps://www.nature.com/articles/s41746-026-03060-zhttps://www.nature.com/articles/s41746-026-03060-zSat, 08 Aug 2026 00:00:00 GMTJournalshttps://www.nature.com/articles/s41746-026-03110-6https://www.nature.com/articles/s41746-026-03110-6Sat, 08 Aug 2026 00:00:00 GMTJournalshttps://www.nature.com/articles/s41746-026-03061-yhttps://www.nature.com/articles/s41746-026-03061-ySat, 08 Aug 2026 00:00:00 GMTJournalshttps://www.nature.com/articles/s41746-026-03102-6https://www.nature.com/articles/s41746-026-03102-6Sat, 08 Aug 2026 00:00:00 GMTJournalshttps://www.nature.com/articles/s41746-026-03086-3https://www.nature.com/articles/s41746-026-03086-3Sat, 08 Aug 2026 00:00:00 GMTJournalshttp://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-drug-prevent-new-world-screwworm-multiple-species-includinghttp://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-drug-prevent-new-world-screwworm-multiple-species-includingFDA today issued an Emergency Use Authorization (EUA) for CLiK Extra (dicyclanil topical suspension) wound spray for application on or around wounds for the prevention of New World screwworm (NWS) infestations (myiasis).Fri, 07 Aug 2026 13:00:09 GMTRegulators & agencieshttps://www.medrxiv.org/content/10.64898/2026.08.05.26359828v1?rss=1https://www.medrxiv.org/content/10.64898/2026.08.05.26359828v1?rss=1Background: High intensity statins are foundational after acute coronary syndrome (ACS), yet intensive care unit prescribing occurs while renal reserve, perfusion, and interacting therapies are changing. We tested a renal safety checkpoint integrating kidney…Fri, 07 Aug 2026 00:00:00 GMTPreprintshttps://www.medrxiv.org/content/10.64898/2026.08.05.26359771v1?rss=1https://www.medrxiv.org/content/10.64898/2026.08.05.26359771v1?rss=1Objective We aimed to evaluate the performance of the recently updated Sequential Organ Failure Assessment Score-2 (SOFA-2) on organ dysfunction classification and prognostication compared to SOFA-1 in critically injured trauma patients. Methods Adult trauma…Fri, 07 Aug 2026 00:00:00 GMTPreprintshttps://www.medrxiv.org/content/10.64898/2026.08.05.26359761v1?rss=1https://www.medrxiv.org/content/10.64898/2026.08.05.26359761v1?rss=1Background Women living with Human Immunodeficiency Virus (WLHIV) are at high risk of cervical cancer. While Human Papilloma Virus Deoxyribonucleic acid (HPV DNA) testing is the standard of care, its cost limits widespread use in resource-limited settings,…Fri, 07 Aug 2026 00:00:00 GMTPreprintshttps://www.medrxiv.org/content/10.64898/2026.08.04.26359742v1?rss=1https://www.medrxiv.org/content/10.64898/2026.08.04.26359742v1?rss=1Frailty is a common consequence of aging that makes individuals increasingly susceptible to adverse health outcomes. Frailty screening can identify pre-frail and frail individuals to prescribe interventions or inform clinical decision making to prevent or…Fri, 07 Aug 2026 00:00:00 GMTPreprintshttps://www.medrxiv.org/content/10.64898/2026.08.05.26359776v1?rss=1https://www.medrxiv.org/content/10.64898/2026.08.05.26359776v1?rss=1Background: Oral mucositis is a clinically significant, potentially severe side effect of systemic chemotherapy in children with cancer. Understanding genetic predisposition to this side effect may assist in development of stratified prophylactic and…Fri, 07 Aug 2026 00:00:00 GMTPreprintshttps://www.medrxiv.org/content/10.64898/2026.08.05.26359789v1?rss=1https://www.medrxiv.org/content/10.64898/2026.08.05.26359789v1?rss=1Background: Early access to pregnancy assessment units now detects many tubal ectopic pregnancies (TEP) at a stage when they could resolve spontaneously, creating a management dilemma. Methods: We performed a hypothesis-generating exploratory analysis in a…Fri, 07 Aug 2026 00:00:00 GMTPreprintshttps://www.medrxiv.org/content/10.64898/2026.08.05.26359770v1?rss=1https://www.medrxiv.org/content/10.64898/2026.08.05.26359770v1?rss=1Nutritional status and immune function have a significant impact on the prognosis of patients undergoing maintenance hemodialysis (MHD). Previous studies have shown that the Geriatric Nutritional Risk Index (GNRI) and the Prognostic Nutritional Index (PNI) at…Fri, 07 Aug 2026 00:00:00 GMTPreprintshttps://www.medrxiv.org/content/10.64898/2026.08.05.26359757v1?rss=1https://www.medrxiv.org/content/10.64898/2026.08.05.26359757v1?rss=1Introduction: Postgraduate clinical training is crucial for developing professional competence, communication skills, and effective teamwork. Although resident physician selection is crucial, little is known about how Japanese residency programs select…Fri, 07 Aug 2026 00:00:00 GMTPreprintshttp://www.fda.gov/news-events/press-announcements/fda-approves-new-engineered-viral-immunotherapy-patients-treatment-resistant-advanced-melanomahttp://www.fda.gov/news-events/press-announcements/fda-approves-new-engineered-viral-immunotherapy-patients-treatment-resistant-advanced-melanomaThe U.S. Food and Drug Administration today granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg), a genetically modified oncolytic viral therapy for the treatment of advanced, refractory melanoma.Thu, 06 Aug 2026 19:56:59 GMTRegulators & agencieshttp://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treat-full-range-narcolepsy-type-1-symptomshttp://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treat-full-range-narcolepsy-type-1-symptomsThe FDA approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults.Wed, 05 Aug 2026 19:42:58 GMTRegulators & agencieshttp://www.fda.gov/news-events/press-announcements/fda-licenses-first-ever-freeze-dried-plasma-product-ushttp://www.fda.gov/news-events/press-announcements/fda-licenses-first-ever-freeze-dried-plasma-product-usFDA today licensed Ezplaz Freeze Dried Plasma (FDP), making it the first freeze-dried plasma product licensed for use in the United States. Ezplaz is intended for transfusion in adult patients who need plasma and for whom other plasma products are not…Wed, 29 Jul 2026 16:10:31 GMTRegulators & agencieshttp://www.fda.gov/news-events/press-announcements/fda-announces-first-participant-selected-tempo-digital-health-devices-pilothttp://www.fda.gov/news-events/press-announcements/fda-announces-first-participant-selected-tempo-digital-health-devices-pilotThe U.S. Food and Drug Administration today announced the first manufacturer selected for the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot.Wed, 22 Jul 2026 17:57:57 GMTRegulators & agencieshttp://www.fda.gov/news-events/press-announcements/fda-takes-further-steps-remove-outdated-authorizations-color-additives-foodhttp://www.fda.gov/news-events/press-announcements/fda-takes-further-steps-remove-outdated-authorizations-color-additives-foodThe U.S. Food and Drug Administration today announced two actions targeting petroleum-based color additives in food, continuing the agency’s broader efforts to Make America Healthy Again.Wed, 22 Jul 2026 13:10:58 GMTRegulators & agencieshttp://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-pcsk9-inhibitor-lower-ldl-cholesterol-adults-high-cholesterolhttp://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-pcsk9-inhibitor-lower-ldl-cholesterol-adults-high-cholesterolThe U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad”…Fri, 17 Jul 2026 15:01:17 GMTRegulators & agencieshttp://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-drug-short-term-prevention-new-world-screwworm-horseshttp://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-drug-short-term-prevention-new-world-screwworm-horsesThe FDA today issued an Emergency Use Authorization (EUA) for Ivermectin Liquid for Horses (ivermectin oral solution) for the short-term prevention of New World screwworm (NWS) infestations (myiasis) in horses when administered within 24 hours of birth or at…Wed, 15 Jul 2026 21:04:45 GMTRegulators & agencieshttps://www.who.int/news/item/25-02-2026-who-director-general-visits-jordan-to-recognize-strong-collaboration-on-health-system-delivery--emergency-relief-and-advancing-mental-healthhttps://www.who.int/news/item/25-02-2026-who-director-general-visits-jordan-to-recognize-strong-collaboration-on-health-system-delivery--emergency-relief-and-advancing-mental-healthThe Director-General of the World Health Organization, Dr Tedros Adhanom Ghebreyesus, today concluded the first day of his two-day State visit to the Hashemite Kingdom of Jordan, underscoring the strong partnership between WHO and Jordan across the areas of…Wed, 25 Feb 2026 18:06:55 GMTRegulators & agencieshttps://www.who.int/news/item/24-01-2026-who-statement-on-notification-of-withdrawal-of-the-united-stateshttps://www.who.int/news/item/24-01-2026-who-statement-on-notification-of-withdrawal-of-the-united-statesWHO regrets the United States’ notification of withdrawal from WHO – a decision that makes both the United States and the world less safe. The notification of withdrawal raises issues that will be considered by the WHO Executive Board at its regular meeting…Sat, 24 Jan 2026 20:09:49 GMTRegulators & agencieshttps://www.who.int/news/item/30-07-2025-paying-tribute-to-david-nabarrohttps://www.who.int/news/item/30-07-2025-paying-tribute-to-david-nabarroTribute to Dr David NabarroWed, 30 Jul 2025 08:56:15 GMTRegulators & agencieshttps://www.who.int/news/item/24-07-2025-timor-leste-certified-malaria-free-by-whohttps://www.who.int/news/item/24-07-2025-timor-leste-certified-malaria-free-by-whoThe World Health Organization (WHO) has certified Timor-Leste as malaria-free, a remarkable achievement for a country that prioritized the disease and embarked on a concerted, nation-wide response shortly after gaining independence in 2002. “WHO congratulates…Wed, 23 Jul 2025 10:07:41 GMTRegulators & agencieshttps://www.who.int/news/item/24-05-2025-world-health-organization-and-african-union-renew-strategic-partnership-to-drive-impact-and-strengthen-health-systems-in-africahttps://www.who.int/news/item/24-05-2025-world-health-organization-and-african-union-renew-strategic-partnership-to-drive-impact-and-strengthen-health-systems-in-africaThe World Health Organization (WHO) and the African Union (AU) Commission renewed their longstanding strategic partnership today with the signing of an updated Memorandum of Understanding (MoU) on the sidelines of the 78th World Health Assembly in Geneva.…Sat, 24 May 2025 17:47:21 GMTRegulators & agencieshttps://www.who.int/news/item/19-05-2025-who-s-strategic-engagement-with-philanthropies-advancing-global-health-and-resilient-health-systemshttps://www.who.int/news/item/19-05-2025-who-s-strategic-engagement-with-philanthropies-advancing-global-health-and-resilient-health-systemsPhilanthropic support plays a vital role in enabling countries to build stronger health systems and advance towards health equity. From vaccine equity and pandemic preparedness to primary health care, the contributions of philanthropic partners help drive…Mon, 19 May 2025 11:53:23 GMTRegulators & agencieshttps://www.who.int/news/item/10-04-2025-worldwide-rally-for-maternal-and-newborn-health-marks-world-health-day-2025https://www.who.int/news/item/10-04-2025-worldwide-rally-for-maternal-and-newborn-health-marks-world-health-day-2025On the occasion of the World Health Day 2025 dedicated to the theme of Healthier beginnings, hopeful futures, over 100 global WHO offices have organized wide-ranging public advocacy actions in collaboration with Member States, communities, health workers,…Thu, 10 Apr 2025 15:02:54 GMTRegulators & agencieshttps://www.who.int/news/item/06-03-2025-strengthening-public-health-across-lebanon-with-eib-globalhttps://www.who.int/news/item/06-03-2025-strengthening-public-health-across-lebanon-with-eib-globalDr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), and Thomas Östros, Vice-President of the European Investment Bank (EIB Global), met at the EIB Group Forum in Luxembourg and signed an agreement for a €10 million grant to…Tue, 01 Apr 2025 11:55:48 GMTRegulators & agencieshttps://www.cms.gov/newsroom/fact-sheets/regulatory-alignment-predictable-immediate-device-coverage-pathway-cms-3487-nc-procedural-noticehttps://www.cms.gov/newsroom/fact-sheets/regulatory-alignment-predictable-immediate-device-coverage-pathway-cms-3487-nc-procedural-noticeRegulatory Alignment for Predictable and Immediate Device Coverage Pathway (CMS-3487-NC) Procedural Notice Inviting CommentRegulators & agencieshttps://www.cms.gov/newsroom/press-releases/cms-launches-new-state-toolkit-protect-children-autism-strengthen-oversight-applied-behaviorhttps://www.cms.gov/newsroom/press-releases/cms-launches-new-state-toolkit-protect-children-autism-strengthen-oversight-applied-behaviorCMS Launches New State Toolkit to Protect Children with Autism, Strengthen Oversight of Applied Behavior Analysis Services Resource supports child-centered, evidence-based care while strengthening program integrity, protecting children from inappropriate…Regulators & agencieshttps://www.cms.gov/newsroom/press-releases/readout-cms-celebrates-delivery-health-technology-ecosystem-one-year-after-launchhttps://www.cms.gov/newsroom/press-releases/readout-cms-celebrates-delivery-health-technology-ecosystem-one-year-after-launchReadout: CMS Celebrates Delivery of the Health Technology Ecosystem, One Year After Launch The Centers for Medicare & Medicaid Services (CMS) recently hosted the one-year celebration of the Health Technology Ecosystem, bringing together leaders from the…Regulators & agencieshttps://www.cms.gov/newsroom/fact-sheets/fy-2027-hospital-inpatient-prospective-payment-system-long-term-care-hospital-prospective-paymenthttps://www.cms.gov/newsroom/fact-sheets/fy-2027-hospital-inpatient-prospective-payment-system-long-term-care-hospital-prospective-paymentFY 2027 Hospital Inpatient Prospective Payment System and Long-Term Care Hospital Prospective Payment System Final Rule (CMS-1849-F)Regulators & agencieshttps://www.cms.gov/newsroom/press-releases/cms-news-cms-announces-nationwide-expansion-proven-joint-replacement-programhttps://www.cms.gov/newsroom/press-releases/cms-news-cms-announces-nationwide-expansion-proven-joint-replacement-programCMS Announces Nationwide Expansion of Proven Joint Replacement Program The Centers for Medicare & Medicaid Services (CMS) is expanding an initiative to improve care coordination for hip, knee, and ankle replacements, ensuring providers work together from…Regulators & agencieshttps://www.cms.gov/newsroom/fact-sheets/fy-2027-inpatient-rehabilitation-facilities-irf-prospective-payment-system-pps-final-rule-cms-1845-fhttps://www.cms.gov/newsroom/fact-sheets/fy-2027-inpatient-rehabilitation-facilities-irf-prospective-payment-system-pps-final-rule-cms-1845-fFY 2027 Inpatient Rehabilitation Facilities (IRF) Prospective Payment System (PPS) Final Rule (CMS-1845-F) On July 30, 2026, the Centers for Medicare & Medicaid Services (CMS) issued a final rule that updates Medicare payment policies and rates for inpatient…Regulators & agencies